spironolactone has been researched along with nandrolone decanoate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bourgeois, MO; Bray, GA; Greeson, C; Lovejoy, JC; Macchiavelli, R; Partington, C; Rood, JC | 1 |
| da H Silva, A; dos Santos, MC; Ferraz, EF; Marques Neto, SR; Nascimento, JH | 1 |
| Campos de Carvalho, AC; Ferraz, EB; Marques-Neto, SR; Nascimento, JH; Njaine, B; Rodrigues, DC; Rondinelli, E | 1 |
1 review(s) available for spironolactone and nandrolone decanoate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for spironolactone and nandrolone decanoate
| Article | Year |
|---|---|
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study.
Topics: Adipose Tissue; Androgen Antagonists; Androgens; Body Composition; Cardiovascular Diseases; Female; Hormones; Humans; Nandrolone; Nandrolone Decanoate; Obesity; Postmenopause; Risk Factors; Spironolactone | 1996 |
3 other study(ies) available for spironolactone and nandrolone decanoate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The blockade of angiotensin AT1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction.
Topics: Anabolic Agents; Angiotensin II Type 1 Receptor Blockers; Animals; Heart Diseases; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nandrolone; Nandrolone Decanoate; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone | 2013 |
AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Heart; KATP Channels; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Reperfusion Injury; Myocardium; Nandrolone; Nandrolone Decanoate; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Reperfusion Injury; Spironolactone; Steroids; Ventricular Function, Left | 2014 |